March 31, 2026 at 11:31 am

MISSD Attends the Washington, DC Psychotherapy Networker Symposium, Reaching Thousands of Clinicians

MISSD recently presented at the Washington, DC Psychotherapy Networker Symposium, delivering a Lunch & Learn session focused on the recognition and risks of akathisia.

Akathisia is a serious and often unrecognized medication-induced disorder associated with profound distress and potentially life-threatening outcomes. Early identification remains critical to improving patient safety. During the session, MISSD provided education on:

  • Recognizing akathisia in clinical and real-world settings
  • The importance of assessing symptoms in relation to medication changes
  • Strategies to support earlier identification and reduce misdiagnosis

In addition to the presentation, MISSD maintained an exhibit presence throughout the symposium, engaging with thousands of attending clinicians and distributing educational materials to expand awareness of medication-induced harm.

MISSD also highlighted its free accredited online courses, developed to support clinicians, patients, and caregivers in recognizing akathisia and improving safety outcomes.

Register for the courses at MISSD.LearnUpon.com

MISSD continues its national and international efforts to advance recognition, education, and prevention of medication-induced harm that can cause self-harm, violence, and suicide.

Kristina Kaiser (l) and Wendy Dolin discuss adverse medication effects that can cause psychiatric symptoms at the Psychotherapy Networker Symposium in Washington, D.C.

MISSD founder, Wendy Dolin, and therapist Dr. Linda Stern prepare to greet symposium attendees and share MISSD’s educational resources.